Modeling the effect of tat inhibitors on HIV latency

Luis U Aguilera1, Jesús Rodríguez-González2

  • 1Department of Modeling of Biological Processes, COS Heidelberg / Bioquant, Heidelberg University, Im Neuenheimer Feld 267, Heidelberg 69120, Germany; Colorado State University.

Insights

Developing a cure for acquired immunodeficiency syndrome (AIDS) requires eradicating latent human immunodeficiency virus (HIV) reservoirs. Tat inhibitors show potential, with compounds disrupting the viral genome offering more permanent suppression.

Area of Science:

  • Virology
  • Computational Biology
  • Drug Discovery

Background:

  • Acquired immunodeficiency syndrome (AIDS) treatment advances stall disease progression but do not provide a cure.
  • Eradicating latent human immunodeficiency virus (HIV) reservoirs is crucial for an HIV cure.
  • The viral protein Tat plays a significant role in establishing HIV latency.

Purpose of the Study:

  • To investigate the potential of Tat inhibitors as virus-suppressing agents using a mathematical model.
  • To understand the intracellular dynamics of HIV replication concerning Tat protein.

Main Methods:

  • Implementation of a computational model simulating intracellular HIV dynamics.
  • Simulation of Tat protein removal and interaction with the viral genome.

Main Results:

  • Tat inhibitors caused temporary and reversible viral suppression by removing Tat protein.
  • Compounds disrupting the integrated viral genome via Tat interaction led to more permanent viral suppression.

Conclusions:

  • Targeting HIV latency through Tat inhibition is a viable strategy for viral suppression.
  • Disrupting the integrated viral genome offers a more promising approach for long-term HIV remission.

Related Concept Videos

Psychosexual Stages of Personality: Latency01:16

Psychosexual Stages of Personality: Latency

Following the phallic stage in Freud's theory of psychosexual development, children enter a phase called the latency period, which lasts from approximately six to twelve years of age. Unlike earlier stages, where sexual impulses played a central role, Freud believed these impulses are repressed during the latency period, becoming part of the unconscious. This stage is often described as a time of psychological calm after the turbulence of the phallic stage.
The latency period is not...
1.2K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.9K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
622
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.4K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.4K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
586